These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 13683555)

  • 21. [EFFECT OF FENOHARMAN ON THE EXCRETION OF 5-HYDROXYINDOLACETIC AND 3-METHOXY-4HYDROXYMANDELIC ACID IN MAN].
    RYSANEK K; VITEK V; VOJTECHOVSKY M; KUHN E
    Cas Lek Cesk; 1963 Oct; 102():1099-102. PubMed ID: 14054236
    [No Abstract]   [Full Text] [Related]  

  • 22. [Urinary elimination of 5-hydroxyindolacetic acid in normal children].
    SERRA U
    Folia Endocrinol Mens Incretologia Incretoterapia; 1958 Aug; 11(4):410-7. PubMed ID: 13609704
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of some chlororganic pesticides on serotonin metabolism].
    Khaĭkina BI; Shilina VF
    Farmakol Toksikol; 1971; 34(3):357-9. PubMed ID: 4105530
    [No Abstract]   [Full Text] [Related]  

  • 24. [Release of endogenous histamine in man and urinary excretion of 5-hydroxyindolacetic acid].
    LECOMTE J; FISCHER P
    Acta Allergol; 1958; 12(4-5):240-4. PubMed ID: 13594028
    [No Abstract]   [Full Text] [Related]  

  • 25. [5-oxyindolacetic acid in some skin diseases].
    Kulaga VV; Grebennikov VA; Telegina SA
    Vestn Dermatol Venerol; 1972 Jan; 46(1):39-43. PubMed ID: 5011890
    [No Abstract]   [Full Text] [Related]  

  • 26. [The determination of 5-hydroxy-indolacetic acid in acute coronary insufficiency].
    ANGELINO PF; CROLLE G; PELLEGRINI A; TARTARA D; PASSAGGIO AM; PAGANO PG
    Presse Med (1893); 1961 Apr; 69():728. PubMed ID: 13683553
    [No Abstract]   [Full Text] [Related]  

  • 27. [Urinary excretion of 5-hydroxyindolacetic acid (5-HIAA) in 150 patients with depressive syndrome and maniacal agitation. (Its modifications by 5-hydroxy-tryptophan loading and therapy in the depressive states)].
    BURGERMEISTER JJ; DICK P; GARONNE G; GUGGISBERG M; TISSOT R
    Presse Med (1893); 1963 May; 71():1116-8. PubMed ID: 14016979
    [No Abstract]   [Full Text] [Related]  

  • 28. [Letter: Urinary diagnostics in precancerous conditions?].
    Dold U
    Dtsch Med Wochenschr; 1974 Jul; 99(27):1476. PubMed ID: 4462608
    [No Abstract]   [Full Text] [Related]  

  • 29. Gas chromatographic determination of urinary indole-3-acetic acid.
    Naruse H; Kato N; Nasu E; Kawai S; Hashimoto K; Masada Y; Ohno T
    Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):2032-4. PubMed ID: 922984
    [No Abstract]   [Full Text] [Related]  

  • 30. [Investigations on the excretion of 5-hydroxy-indolacetic acid].
    GELLER W
    Psychiatr Neurol (Basel); 1960 Jul; 140():55-6. PubMed ID: 13704293
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interference with the urine analysis of etodolic acid].
    Kutter D; Al Haidari K; Hemmer P
    Pharm Acta Helv; 1988; 63(3):93-6. PubMed ID: 2970648
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the elimination of 5-hydroxyindolacetic acid in normal subjects and in liver patients].
    PASSERI M
    Boll Soc Ital Biol Sper; 1960 Dec; 36():1355-7. PubMed ID: 13733172
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of indolacetic acid in urine by paper partition chromatography].
    PACHECO H
    C R Hebd Seances Acad Sci; 1953 Jul; 237(1):110-1. PubMed ID: 13082780
    [No Abstract]   [Full Text] [Related]  

  • 34. Dynamics of 17-OHCS excretion in chronic coronary insufficiency.
    Kraska T; Lada W; Tymińska K
    Acta Med Pol; 1980; 21(3):257-67. PubMed ID: 7246219
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes of fibrinogenemia in myocardial infarct and coronary insufficiency].
    DJORDJEVIC BS; STRASER T
    Srp Arh Celok Lek; 1961 Feb; 89():127-30. PubMed ID: 13723181
    [No Abstract]   [Full Text] [Related]  

  • 36. [The determination of 5-hydroxyindolacetic acid by means of high-tension electrophoresis].
    STURM A
    Clin Chim Acta; 1962 Sep; 7():714-21. PubMed ID: 13978983
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in serotonin metabolism in patients with hypertension].
    Sabirova RKh; Farkhutdinov RG
    Kardiologiia; 1972 Aug; 12(8):19-22. PubMed ID: 4642630
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biochemical demonstration of myocardial necrobiosis during chronic coronary insufficiency without infarct].
    GIBINSKI K
    Pol Tyg Lek (Wars); 1958 Jun; 13(22):821-6. PubMed ID: 13578749
    [No Abstract]   [Full Text] [Related]  

  • 39. [EFFECTS OF EXPOSURE TO LEAD ON THE ELIMINATION OF 5-HYDROXYINDOLACETIC ACID].
    CORSI GC; BRUGNONE F; DANIELI A
    Minerva Med; 1963 Oct; 54():3097-9. PubMed ID: 14098410
    [No Abstract]   [Full Text] [Related]  

  • 40. [The urinary determination of a catabolite of serotonin (5-hydroxyindolacetic acid) in coronary insufficiency with or without myocardial infarct].
    ANGELINO PF; PELLEGRINI A; CROLLE G; PAGANO PG; TARTARA D
    Minerva Med; 1961 Jun; 52():2193-6. PubMed ID: 13683555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.